发明名称 |
AEROSOLIZABLE PHARMACEUTICAL FORMULATION FOR FUNGAL INFECTION THERAPY |
摘要 |
A method of treating and/or providing prophylaxis against a pulmonary fungal infection comprises delivering an aerosolized pharmaceutical formulation comprising an antifungal agent to the lungs. The method comprises determining the minimum inhibitory concentration of the antifungal agent for inhibiting pulmonary fungal growth. A sufficient amount of the pharmaceutical formulation is administered to maintain for a period of time a target antifungal agent lung concentration that is greater than the determined minimum inhibitory concentration. In one version, the antifungal agent is amphotericin B.
|
申请公布号 |
KR20050088242(A) |
申请公布日期 |
2005.09.02 |
申请号 |
KR20057012393 |
申请日期 |
2005.06.30 |
申请人 |
NEKTAR THERAPEUTICS |
发明人 |
WEERS JEFFRY G.;TARARA THOMAS E.;ELDON MICHAEL A.;NARASIMHAN RANGACHARI |
分类号 |
A61K9/00;A61K9/16;A61K31/00;A61K31/496;(IPC1-7):A61K9/12;C07H19/00 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|